ArticleJournal of virology2005
Comprehensive bioinformatic analysis of the specificity of human immunodeficiency virus type 1 protease.
Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 60 citations in OpenAlex.
- HIV-1 protease cleavage sites detection with a quantum convolutional neural network algorithm.Scientific reports · 2026Article
- Integrative modeling of diverse protein-peptide systems using CABS-dock.PLoS computational biology · 2023Article
- Prediction of HIV-1 protease cleavage site from octapeptide sequence information using selected classifiers and hybrid descriptors.BMC bioinformatics · 2022Article
- SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis.Computational biology and chemistry · 2022Article
- Predicting HIV-1 Protease Cleavage Sites With Positive-Unlabeled Learning.Frontiers in genetics · 2021Article
- Prediction of HIV-1 protease cleavage site using a combination of sequence, structural, and physicochemical features.BMC bioinformatics · 2016Article
- The importance of physicochemical characteristics and nonlinear classifiers in determining HIV-1 protease specificity.Bioengineered · 2016Article
- Feature Selection Combined with Neural Network Structure Optimization for HIV-1 Protease Cleavage Site Prediction.BioMed research international · 2015Article
- A consistency-based feature selection method allied with linear SVMs for HIV-1 protease cleavage site prediction.PloS one · 2013Article
- Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability.Journal of molecular modeling · 2011Article
- Predicting human immunodeficiency virus protease cleavage sites in nonlinear projection space.Molecular and cellular biochemistry · 2010Article
- Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance.Structure (London, England : 1993) · 2009Article
- How to find simple and accurate rules for viral protease cleavage specificities.BMC bioinformatics · 2009Article
- Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.Journal of virology · 2007Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapidly developing viral resistance to licensed human immunodeficiency virus type 1 (HIV-1) protease inhibitors is an increasing problem in the treatment of HIV-infected individuals and AIDS patients. A rational design of more effective protease inhibitors and discovery of potential biological substrates for the HIV-1 protease require accurate models for protease cleavage specificity. In this study, several popular bioinformatic machine learning methods, including support vector machines and artificial neural networks, were used to analyze the specificity of the HIV-1 protease. A new, extensive data set (746 peptides that have been experimentally tested for cleavage by the HIV-1 protease) was compiled, and the data were used to construct different classifiers that predicted whether the protease would cleave a given peptide substrate or not. The best predictor was a nonlinear predictor using two physicochemical parameters (hydrophobicity, or alternatively polarity, and size) for the amino acids, indicating that these properties are the key features recognized by the HIV-1 protease. The present in silico study provides new and important insights into the workings of the HIV-1 protease at the molecular level, supporting the recent hypothesis that the protease primarily recognizes a conformation rather than a specific amino acid sequence. Furthermore, we demonstrate that the presence of 1 to 2 lysine residues near the cleavage site of octameric peptide substrates seems to prevent cleavage efficiently, suggesting that this positively charged amino acid plays an important role in hindering the activity of the HIV-1 protease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.